Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Accounts Payable & Accrued Expense : ¥147.0 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Jibeier Pharmaceutical Co Accounts Payable & Accrued Expense?

Jiangsu Jibeier Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥184.3 Mil) to Dec. 2023 (¥198.4 Mil) but then declined from Dec. 2023 (¥198.4 Mil) to Mar. 2024 (¥147.0 Mil).

Jiangsu Jibeier Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥122.4 Mil) to Dec. 2022 (¥176.9 Mil) and increased from Dec. 2022 (¥176.9 Mil) to Dec. 2023 (¥198.4 Mil).

Jiangsu Jibeier Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jiangsu Jibeier Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Jibeier Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Jiangsu Jibeier Pharmaceutical Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

63.55

82.87

122.36

176.87

198.36

Jiangsu Jibeier Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															133.44	197.19	184.32	198.36	147.02

Jiangsu Jibeier Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Jibeier Pharmaceutical Co Ltd (SHSE:688566) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000

Website

http://www.jibeier.com.cn

Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.

Executives

Wu Ying	senior management
Zhang Chun	Director
Zhao Suo Fu	senior management
Li Hai Dao	Core technical personnel
Di Jian Zhong	senior management
Qin Xu Feng	Core technical personnel
Wu Xiu Gen	Core technical personnel
Yu Xin Jun	Directors, senior managers
Hu Tao	Director

Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Headlines

No Headlines